Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and EPO in Chronic Stroke and ALS
NCT00298597Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Mar 2006
- Primary completion
- Mar 2009
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stroke and amyotrophic lateral sclerosis (ALS) comparing G-CSF + EPO with Placebo (2 arms). Primary endpoints: Learning success in a word learning model and Response time in motor function tests. Started Mar 2006; status: completed.
02
Drugs
granulocyte colony-stimulating factorerythropoietin
03
Conditions
strokeamyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00298597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298597.